Board Certifications: Hematology, Internal Medicine and Medical Oncology
Locations: Hackensack, NJ
Harsh Parmar, MD, specializes in the treatment of patients with multiple myeloma and other plasma cell disorders, such as amyloidosis and Waldenstrom’s macroglobulinemia. He chose to specialize in the care of patients with these diseases because there are no current treatment options that result in a cure, and there are opportunities to make advances in the management of these cancers. He joined John Theurer Cancer Center at Hackensack University Medical Center in 2020.
When he meets new patients, Dr. Parmar takes a caring attitude and treats them with compassion. The treatment of these cancers may extend over years as patients go into remission and then relapse. Dr. Parmar enjoys getting to know his patients, including their preferences and goals of therapy. In addition to standard therapies, he is interested in clinical trials of innovative therapies that hold promise for extending patients’ lives. Dr. Parmar received his medical degree from Seth GS Medical College and King Edward Memorial Hospital in Mumbai, India. He continued as an Internal Medicine resident at Jersey Shore University Medical Center, completed a Hematology/Oncology fellowship at the University of Connecticut Health Center, and had additional training as an Advanced Hematology Fellow at the Mayo Clinic. Dr. Parmar is a member of the American Society of Hematology and American Society of Clinical Oncology.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.